184 related articles for article (PubMed ID: 27310005)
21. Factors affecting cervical cancer screening uptake, visual inspection with acetic acid positivity and its predictors among women attending cervical cancer screening service in Addis Ababa, Ethiopia.
Fentie AM; Tadesse TB; Gebretekle GB
BMC Womens Health; 2020 Jul; 20(1):147. PubMed ID: 32677933
[TBL] [Abstract][Full Text] [Related]
22. Understanding the heterogeneity of cervical cancer screening non-participants: Data from a national sample of British women.
Marlow LAV; Chorley AJ; Haddrell J; Ferrer R; Waller J
Eur J Cancer; 2017 Jul; 80():30-38. PubMed ID: 28535495
[TBL] [Abstract][Full Text] [Related]
23. Cervical cancer screening uptake in women aged between 15 and 64 years in Mozambique.
Brandão M; Tulsidás S; Damasceno A; Silva-Matos C; Carrilho C; Lunet N
Eur J Cancer Prev; 2019 Jul; 28(4):338-343. PubMed ID: 30020115
[TBL] [Abstract][Full Text] [Related]
24. A comparison of two visual inspection methods for cervical cancer screening among HIV-infected women in Kenya.
Huchko MJ; Sneden J; Leslie HH; Abdulrahim N; Maloba M; Bukusi E; Cohen CR
Bull World Health Organ; 2014 Mar; 92(3):195-203. PubMed ID: 24700979
[TBL] [Abstract][Full Text] [Related]
25. Building capacity for cervical cancer screening in outpatient HIV clinics in the Nyanza province of western Kenya.
Huchko MJ; Bukusi EA; Cohen CR
Int J Gynaecol Obstet; 2011 Aug; 114(2):106-10. PubMed ID: 21620403
[TBL] [Abstract][Full Text] [Related]
26. Real-World Cervical Cancer Screening Uptake and Predictors of Visual Inspection With Acetic Acid Positivity Among Women Living With HIV in Care Programs in Western Kenya.
Mungo C; Orang'o O; Ofner S; Musick B; Yiannoutsos C; Cohen CR; Brown D; Wools-Kaloustian K; Semeere A
JCO Glob Oncol; 2024 Feb; 10():e2300311. PubMed ID: 38359369
[TBL] [Abstract][Full Text] [Related]
27. Cervical screening uptake and its predictors among rural women in Malaysia.
Gan DE; Dahlui M
Singapore Med J; 2013 Mar; 54(3):163-8. PubMed ID: 23546031
[TBL] [Abstract][Full Text] [Related]
28. Cervical cancer screening uptake and challenges in Malawi from 2011 to 2015: retrospective cohort study.
Msyamboza KP; Phiri T; Sichali W; Kwenda W; Kachale F
BMC Public Health; 2016 Aug; 16(1):806. PubMed ID: 27535359
[TBL] [Abstract][Full Text] [Related]
29. Uptake of breast and cervical cancer screening in four Gulf Cooperation Council countries.
So VHT; Channon AA; Ali MM; Merdad L; Al Sabahi S; Al Suwaidi H; Al Ajeel A; Osman N; Khoja TAM
Eur J Cancer Prev; 2019 Sep; 28(5):451-456. PubMed ID: 30260812
[TBL] [Abstract][Full Text] [Related]
30. Social disparities in access to breast and cervical cancer screening by women living in Spain.
Ricardo-Rodrigues I; Jiménez-García R; Hernández-Barrera V; Carrasco-Garrido P; Jiménez-Trujillo I; López de Andrés A
Public Health; 2015 Jul; 129(7):881-8. PubMed ID: 25818014
[TBL] [Abstract][Full Text] [Related]
31. Cervical cancer screening "see and treat approach": real-life uptake after invitation and associated factors at health facilities in Gondar, Northwest Ethiopia.
Destaw A; Midaksa M; Addissie A; Kantelhardt EJ; Gizaw M
BMC Cancer; 2021 Sep; 21(1):1031. PubMed ID: 34530761
[TBL] [Abstract][Full Text] [Related]
32. A randomized trial comparing the diagnostic accuracy of visual inspection with acetic acid to Visual Inspection with Lugol's Iodine for cervical cancer screening in HIV-infected women.
Huchko MJ; Sneden J; Zakaras JM; Smith-McCune K; Sawaya G; Maloba M; Bukusi EA; Cohen CR
PLoS One; 2015; 10(4):e0118568. PubMed ID: 25849627
[TBL] [Abstract][Full Text] [Related]
33. CRYOTHERAPY FOLLOWING VISUAL INSPECTION WITH ACETIC ACID AND LUGOL'S IODINE (VIA/VILI) IN KHWISERO, WESTERN KENYA: LESSON FROM THE FIELD AFFECTING POLICY AND PRACTICE.
Ngichabe SK; Muthaura PN; Murungi C; Muyoka J; Omenge E; Muchiri L
East Afr Med J; 2013 Oct; 90(10):316-23. PubMed ID: 26862641
[TBL] [Abstract][Full Text] [Related]
34. Cervical cancer screening in Korean American women: findings from focus group interviews.
Kim H; Lee KJ; Lee SO; Kim S
Taehan Kanho Hakhoe Chi; 2004 Jun; 34(4):617-24. PubMed ID: 15502427
[TBL] [Abstract][Full Text] [Related]
35. Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.
Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Lerdlukanavonge P; Koonchote S
Int J Epidemiol; 1995 Jun; 24(3):493-8. PubMed ID: 7672887
[TBL] [Abstract][Full Text] [Related]
36. Socioeconomic disparity in cervical cancer screening among Korean women: 1998-2010.
Lee M; Park EC; Chang HS; Kwon JA; Yoo KB; Kim TH
BMC Public Health; 2013 Jun; 13():553. PubMed ID: 23742100
[TBL] [Abstract][Full Text] [Related]
37. Uptake and correlates of cervical cancer screening among HIV-infected women attending HIV care in Uganda.
Wanyenze RK; Bwanika JB; Beyeza-Kashesya J; Mugerwa S; Arinaitwe J; Matovu JKB; Gwokyalya V; Kasozi D; Bukenya J; Makumbi F
Glob Health Action; 2017; 10(1):1380361. PubMed ID: 29035163
[TBL] [Abstract][Full Text] [Related]
38. Jordanian women's attitudes towards cervical cancer screening: has the pattern changed?
Asali F; Abdel-Razeq R; Al-Thunaibat A; Okour A; Abu Mahfouz S; Abu Mahfouz I
J Obstet Gynaecol; 2020 May; 40(4):564-568. PubMed ID: 31478428
[TBL] [Abstract][Full Text] [Related]
39. Assessment of psychological barriers to cervical cancer screening among women in Kumasi, Ghana using a mixed methods approach.
Williams M; Kuffour G; Ekuadzi E; Yeboah M; ElDuah M; Tuffour P
Afr Health Sci; 2013 Dec; 13(4):1054-61. PubMed ID: 24940332
[TBL] [Abstract][Full Text] [Related]
40. Perspectives of Screening-Eligible Women and Male Partners on Benefits of and Barriers to Treatment for Precancerous Lesions and Cervical Cancer in Kenya.
Ragan KR; Buchanan Lunsford N; Lee Smith J; Saraiya M; Aketch M
Oncologist; 2018 Jan; 23(1):35-43. PubMed ID: 28798272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
